Clinical Trial Update: DNA-based Influenza Vaccine in the Elderly [Phase 1]

View source ↗

Summary

Phase 1 study of a DNA-based influenza vaccine in elderly participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infections
• Viral Infections

Snippet

Sponsor: University of Manitoba | Conditions: Influenza, Human, Orthomyxoviridae Infections | Phase 1 | Status: COMPLETED